Recent progress in understanding Alzheimer's β-amyloid structures

被引:136
|
作者
Faendrich, Marcus [1 ,2 ]
Schmidt, Matthias [1 ,2 ,3 ,4 ]
Grigorieff, Nikolaus [3 ,4 ]
机构
[1] Max Planck Res Unit Enzymol Prot Folding, D-01620 Halle, Saale, Germany
[2] Univ Halle Wittenberg, D-01620 Halle, Saale, Germany
[3] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA
[4] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA
关键词
A-BETA; EXPERIMENTAL CONSTRAINTS; QUATERNARY STRUCTURE; ELECTRON-MICROSCOPY; SOLVENT PROTECTION; PROTEIN OLIGOMERS; FIBRIL FORMATION; SHEET STRUCTURES; DISEASE; PEPTIDE;
D O I
10.1016/j.tibs.2011.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The formation of amyloid fibrils, protofibrils and oligomers from the beta-amyloid (A beta) peptide represents a hallmark of Alzheimer's disease. A beta-peptide-derived assemblies might be crucial for disease onset, but determining their atomic structures has proven to be a major challenge. Progress over the past 5 years has yielded substantial new data obtained with improved methodologies including electron cryo-microscopy and NMR. It is now possible to resolve the global fibril topology and the cross-beta sheet organization within protofilaments, and to identify residues that are crucial for stabilizing secondary structural elements and peptide conformations within specific assemblies. These data have significantly enhanced our understanding of the mechanism of A beta aggregation and have illuminated the possible relevance of specific conformers for neurodegenerative pathologies.
引用
收藏
页码:338 / 345
页数:8
相关论文
共 50 条
  • [41] Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics
    Selkoe, DJ
    Schenk, D
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 : 545 - 584
  • [42] Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
    Madav, Yamini
    Wairkar, Sarika
    Prabhakar, Bala
    BRAIN RESEARCH BULLETIN, 2019, 146 : 171 - 184
  • [43] Amyloid-β as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature
    Wang, Xiaoni
    Sun, Yu
    Li, Taoran
    Cai, Yanning
    Han, Ying
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (03) : 819 - 832
  • [44] RECENT PROGRESS IN CAROTENOID STRUCTURES
    EUGSTER, CH
    CAROTENOIDS: CHEMISTRY AND BIOLOGY, 1989, : 1 - 20
  • [45] Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease
    Singh, Shreya
    Singh, Rakesh Kumar
    MOLECULAR BIOLOGY REPORTS, 2025, 52 (01)
  • [46] Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications
    Creed, Meaghan C.
    Milgram, Norton W.
    AGE, 2010, 32 (03) : 365 - 384
  • [47] Views on amyloid hypothesis and secretase inhibitors for treating Alzheimer's disease: Progress and problems
    Nguyen, Jeffrey-Tri
    Yamani, Abdellah
    Kiso, Yoshiaki
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (33) : 4295 - 4312
  • [48] Amyloid-modifying therapies for Alzheimer’s disease: therapeutic progress and its implications
    Meaghan C. Creed
    Norton W. Milgram
    AGE, 2010, 32 : 365 - 384
  • [49] Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β
    Cohen, Mark L.
    Kim, Chae
    Haldiman, Tracy
    ElHag, Mohamed
    Mehndiratta, Prachi
    Pichet, Termsarasab
    Lissemore, Frances
    Shea, Michelle
    Cohen, Yvonne
    Chen, Wei
    Blevins, Janis
    Appleby, Brian S.
    Surewicz, Krystyna
    Surewicz, Witold K.
    Sajatovic, Martha
    Tatsuoka, Curtis
    Zhang, Shulin
    Mayo, Ping
    Butkiewicz, Mariusz
    Haines, Jonathan L.
    Lerner, Alan J.
    Safar, Jiri G.
    BRAIN, 2015, 138 : 1009 - 1022
  • [50] Tracing amyloid in Alzheimer's
    Taylor, Phil
    CHEMISTRY WORLD, 2009, 6 (12): : 17 - 17